Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Antifibrinolytic MDCO-2010 safe in first-in-patient trial

Oct. 18, 2011

First-in-patient study assesses EMD-525797 in metastatic CRPC

Oct. 18, 2011

Results made available from MENZA trial of enzastaurin

Oct. 18, 2011

Migalastat hydrochloride evaluated in female patients with Fabry's disease

Oct. 17, 2011

Ongoing trial assesses modafinil in postoperative cognitive dysfunction

Oct. 17, 2011

Gene therapy for hemophilia B evaluated in rhesus macaques

Oct. 17, 2011

New clinical data presented on novel HIV integrase inhibitor

Oct. 17, 2011

FOB Synthesis describes new carbapenem with activity against multidrug-resistant bacteria

Oct. 17, 2011

Studies provide overview of data on novel antibacterial LFF-571

Oct. 17, 2011

Phase I trials assess efatutazone in Japanese and Korean patients with advanced solid tumors

Oct. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...